Your browser doesn't support javascript.
loading
Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia.
Kantarjian, Hagop; Haddad, Fadi G; Jain, Nitin; Sasaki, Koji; Short, Nicholas J; Loghavi, Sanam; Kanagal-Shamanna, Rashmi; Jorgensen, Jeffrey; Khouri, Issa; Kebriaei, Partow; Alvarado, Yesid; Kadia, Tapan; Paul, Shilpa; Garcia-Manero, Guillermo; Dabaja, Bouthaina; Yilmaz, Musa; Jacob, Jovitta; Garris, Rebecca; O'Brien, Susan; Ravandi, Farhad; Jabbour, Elias.
Affiliation
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA. hkantarjian@mdanderson.org.
  • Haddad FG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
  • Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
  • Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
  • Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
  • Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Jorgensen J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Khouri I; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Kebriaei P; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Alvarado Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
  • Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
  • Paul S; Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
  • Dabaja B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
  • Jacob J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
  • Garris R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
  • O'Brien S; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA, USA.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 428, Houston, TX, 77030, USA.
J Hematol Oncol ; 16(1): 44, 2023 05 02.
Article de En | MEDLINE | ID: mdl-37131217

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies cardiovasculaires / Leucémie-lymphome lymphoblastique à précurseurs B / Anticorps bispécifiques / Leucémie-lymphome lymphoblastique à précurseurs B et T Type d'étude: Prognostic_studies Limites: Adult / Humans Langue: En Journal: J Hematol Oncol Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies cardiovasculaires / Leucémie-lymphome lymphoblastique à précurseurs B / Anticorps bispécifiques / Leucémie-lymphome lymphoblastique à précurseurs B et T Type d'étude: Prognostic_studies Limites: Adult / Humans Langue: En Journal: J Hematol Oncol Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni